Stock Market News

1 week Agios Crashes 21% After A Surprise Side Effect Hammered Its ‘Very Safe’ Drug Investor's Business Daily

Shares of Agios Pharmaceuticals collapsed Monday on an unexpected side effect related to the company’s thalassemia treatment, mitapivat.
The post Agios Crashes 21% After A Surprise Side Effect Hammered Its 'Very Safe' Drug appeared first on I…

Pharmaceuticals

34 mins Corvus Pharmaceuticals stock rebounds on positive trial results Investing.com

20 hours Stocks making the biggest moves midday: Pfizer, Broadcom, Teva Pharmaceuticals and more CNBC

21 hours NVS vs. LLY: Which Stock Should Value Investors Buy Now? Zacks

22 hours 4 Big Drug Stocks That May Continue to Outperform in 2025 Zacks

23 hours Novo Nordisk A/S (NVO) is Attracting Investor Attention: Here is What You Should Know Zacks

2 days Why Vertex Pharmaceuticals (VRTX) Outpaced the Stock Market Today Zacks

2 days BMY vs. VRTX: Which Stock Is the Better Value Option? Zacks

3 days Tarsus Pharmaceuticals & SpringWorks Therapeutics: Jonathan Faison’s Top 2 Picks Seeking Alpha

3 days Inovio Pharmaceuticals: The Dangerous Allure Of A Falling Knife Seeking Alpha

5 days Regeneron Down 15.5% Year to Date: How to Play the Stock? Zacks

6 days Xenon Pharmaceuticals (XENE) Up 2.4% Since Last Earnings Report: Can It Continue? Zacks

6 days Why Is Mirum Pharmaceuticals (MIRM) Down 0.7% Since Last Earnings Report? Zacks

7 days Phathom Pharmaceuticals: The Large Drop Is, Well, Unfathomable Seeking Alpha

7 days Reviva Pharmaceuticals: Upcoming Events May Generate Excitement, But Cash Is Low Seeking Alpha

7 days Vertex Pharmaceuticals: Progress Check Suggests Stock Remains A Solid Buy Seeking Alpha

7 days How Much Upside is Left in Ionis Pharmaceuticals (IONS)? Wall Street Analysts Think 55.91% Zacks

1 week Vertex Pharmaceuticals (VRTX) Falls More Steeply Than Broader Market: What Investors Need to Know Zacks

1 week Tarsus Pharmaceuticals: Early Rollout Exceeding Expectations Seeking Alpha

1 week Here’s Why Agios Stock Plummeted More Than 20% on Monday Zacks

1 week Implied Volatility Surging for Aurinia Pharmaceuticals (AUPH) Stock Options Zacks

1 week Should You Invest in the Invesco Pharmaceuticals ETF (PJP)? Zacks

1 week BioCryst Pharmaceuticals: Seasoned Blockbuster Makes It A Buy Seeking Alpha

1 week Catalyst Pharmaceuticals: Agamree Is Its Key To A Sustainable Future Seeking Alpha

2 weeks Rhythm Pharmaceuticals: A Key Year Ahead Seeking Alpha

2 weeks Ionis Pharmaceuticals (IONS) Down 4.5% Since Last Earnings Report: Can It Rebound? Zacks

2 weeks Acadia (ACAD) Down 2.9% Since Last Earnings Report: Can It Rebound? Zacks

2 weeks Eli Lilly to Invest $3B in Wisconsin Plant to Meet Obesity Drug Demand Zacks

2 weeks Down -54.05% in 4 Weeks, Here’s Why Phathom Pharmaceuticals (PHAT) Looks Ripe for a Turnaround Zacks

2 weeks Regeneron Pharmaceuticals, Inc. (REGN) Piper Sandler 36th Annual Healthcare Conference (Transcript) Seeking Alpha

2 weeks Why Is Apellis Pharmaceuticals (APLS) Up 18.4% Since Last Earnings Report? Zacks

2 weeks Are Options Traders Betting on a Big Move in Agios (AGIO) Stock? Zacks

2 weeks The Weight-Loss Battle That Could Rattle Eli Lilly’s $100 Billion Market Investor's Business Daily

2 weeks What Makes Alnylam (ALNY) a New Buy Stock Zacks

2 weeks Why Is Vertex (VRTX) Down 8.6% Since Last Earnings Report? Zacks

2 weeks Wall Street Analysts Think Tarsus Pharmaceuticals (TARS) Could Surge 26.98%: Read This Before Placing a Bet Zacks

2 weeks Investors Heavily Search Vertex Pharmaceuticals Incorporated (VRTX): Here is What You Need to Know Zacks

2 weeks Agios Pharmaceuticals: A Long Overdue Follow Up Seeking Alpha

2 weeks Why Acadia Pharmaceuticals (ACAD) is a Top Momentum Stock for the Long-Term Zacks

2 weeks Here is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock Zacks

2 weeks Implied Volatility Surging for ACADIA Pharmaceuticals (ACAD) Stock Options Zacks

2 weeks Terns Pharma broadens beyond obesity drugs with upbeat data in leukemia trial MarketWatch

2 weeks Coherus BioSciences inks $558.4M deal with Intas Pharmaceuticals; shares rally Investing.com

2 weeks Should Value Investors Buy ANI Pharmaceuticals (ANIP) Stock? Zacks

2 weeks Rocket Pharmaceuticals: Not Bad Valuation But Reflexivity Risks Remain Seeking Alpha

2 weeks Elite Pharmaceuticals Launches Norco in generic $ELTP Reddit

3 weeks GILD vs. VRTX: Which Stock Should Value Investors Buy Now? Zacks

3 weeks Mirum Shares Surge More Than 90% in 6 Months: Here’s Why Zacks

3 weeks Wall Street Analysts Think Jazz (JAZZ) Could Surge 44.37%: Read This Before Placing a Bet Zacks

3 weeks Arrowhead Pharmaceuticals Faces Distribution Risks with Vanscoy Reliance Yahoo Finance

3 weeks Here’s Why Acurx Pharmaceuticals (ACXP) Is a Great ‘Buy the Bottom’ Stock Now Zacks

The Stock Market News

TheStockMarketNews.com is a financial news aggregator for traders and investors that proposes to you the latest breaking news headlines on global financial markets, economy and business. Live trading analysis, opinions and forecasts on current stock market, currencies (Forex), cryptocurrency, commodities futures, ETFs, funds, bonds, rates and more. Disclaimer: by using any material of this website, you acknowledge and agree that TheStockMarketNews.com is not responsible for the content, actions or any legal issues arising from third-party websites; materials of this website are not financial advice or call to actions. Trading and investing in financial instruments involve high risks including the risk of investment loss.